ibrutinibbreast cancernon-Hodgkin lymphomachronic lymphocytic leukaemia
…resent the case of radiation recall dermatitis (RRD) induced by ibrutinib therapy in a patient with a history of breast cancer and non-Ho…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 1,501–1,560 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Rese-cel2SCIg2STK-0122TYRX2Vibostolimab2rTOPO2rhIL-152A. muciniphila2AM2ATTR-012B/F/TAF2BILAG-20042BZN2Bexotegrast2BoNT2Ceftazidime-avibactam-aztreonam2Cloxacillin2Colesevelam2FCSEMS2Fumarate2HP2Inavolisib2Iscalimab2Loberamisal2MTZ2Magic Glue2NAM2ORMDL32Ortho-k2PBMT-sMF2PTZ2Pembro2Peripherin2Surpass Elite2SynKIR-1102Telmisartan2XTRA·42aminophylline2chloroprocaine2lorlatinib26-MP268Ga2Anlotinib2BI 10155502Brimonidine2CALPRO22CAR-M2Cefoperazone/sulbactam2Cy/Flu2FRIDs2Fluticasone2GRemubamab2HFA-152a2Masimo2Obe2Obe-252PITSTOP2Patiromer2PuraStat2Resistin2
Articles mentioning drugs
10,506 articles · page 652 of 876fondaparinuxNSTEMIanti-thrombotic therapyTWH
…tly. The most common prescription error was the prescription of fondaparinux with a DOAC.To improve awareness,These findings were presented …
iT2 prep-BOOSTCarotid atherosclerosisstrokeSiemens Healthineers AGAm J Physiol Heart Circ Physiol
…ealthineers AG, Forchheim, Germany) for carotid artery imaging. iT2 prep-BOOST allows for simultaneous bright and dark-blood imaging Images we…
implantable cardioverter defibrillatorscoronary artery diseaseheart failureHypertrophic cardiomyopathyFaculty of Sport and Exercise MedicinePublic Health EnglandHCM
…ng in patients with HCM?What is the evidence on exercising with implantable cardioverter defibrillators in patients with HCM?What are the effects of physical activity …
AADsthyroid dysfunctioncatheter ablationIron deficiencyVentricular tachycardia (VT)ischaemic cardiomyopathy
… typically managed with a combination of anti-arrhythmic drugs (AADs), catheter ablation, and optimisation of anti-tachycardia thera…
DCBsin-stent restenosisde novo coronary lesionsNational Institute for Cardiovascular Outcomes Researchantiproliferative therapyrestenosisPCI with stent deploymentNICOR
…Background Drug-coated balloons (DCBs) are an established treatment for in-stent restenosis and are i…
atropinecardioinhibitory syncopeintrinsic conduction diseaseatrial ganglionated plexi
…on of left and right atrial ganglionated plexi, with adjunctive atropine testing and vagal stimulation. Three female patients (mean age …
Beta-hydroxybutyrate (BHB)cardiac inflammation
…wever, adherence varies and is difficult to verify objectively. Beta-hydroxybutyrate (BHB), the main circulating ketone, rises with fasting and reflects a…
potent antithromboticsacute coronary syndromesIn-Stent Restenosismultivessel diseaseNational Institute for Cardiovascular Outcomes ResearchDrug-Coated Balloon therapybifurcation diseaseheavily calcified lesionsNICOR
…disease, and bifurcation anatomy, alongside broader adoption of potent antithrombotics and stent-sparing technologies. However, current metrics inadeq…
Interleukin (IL) -1 receptor antagonistChronic inflammationNational Research Ethics ServiceUK Biobanksystemic inflammationcardiac remodeling
… compensatory increased heart rate (β = 1.38; all P < 10^-228). Interleukin (IL) -1 receptor antagonist mediated 27% of the GlycA effect on end-diastolic volume (avera…
LPSIschaemia–reperfusion injury
…lining by day 3 post-surgery. In permeability assays, 100 ng/mL LPS induced significant endothelial hyperpermeability. Co-stimulati…
IV contrastchronic kidney diseaseIpswich Hospitalcontrast-induced nephropathyrenal replacement therapyCINPercutaneous Coronary InterventionCKD
…seline or an increase of 44 µmol/L within 48-72 hours following IV contrast administration. Ultra-low contrast PCI is defined as a ratio of…